|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology. |
| 公司地址
| 4505 Emperor Boulevard, Suite 200, Durham, NC, USA, 27703 |
| 電話號碼
| +1 919 859-1302 |
| 傳真號碼
| +1 919 859-1314 |
| 公司網頁
| https://www.biocryst.com |
| 員工數量
| 435 |
| Mr. Babar Ghias |
Chief Financial Officer, Principal Accounting Officer and Head, Corporate Development |
-- |
26/02/2026 |
| Ms. Alane P. Barnes |
Chief Legal Officer and Corporate Secretary |
美元 525.44K |
24/04/2025 |
| Mr. Charles K. Gayer |
Director, President and Chief Executive Officer |
美元 544.83K |
26/02/2026 |
| Mr. Charlie Gayer |
President, Chief Executive Officer and Director |
-- |
31/07/2025 |
|
|
| Mr. Alan G. Levin |
Independent Director |
26/02/2026 |
| Mr. Jon P. Stonehouse |
Director |
26/02/2026 |
| Mr. Vincent J. Milano |
Chairperson of the Board |
26/02/2026 |
| Dr. Jill C. Milne, PhD |
Director |
26/02/2026 |
| Dr. Steven K. Galson, M.D. |
Independent Director |
26/02/2026 |
| Ms. Theresa M. Heggie |
Independent Director |
26/02/2026 |
| Mr. Charles K. Gayer |
Director, President and Chief Executive Officer |
26/02/2026 |
| Mr. Steven Frank |
Director |
26/02/2026 |
| Ms. A. Machelle Sanders |
Independent Director |
26/02/2026 |
| Mr. Charlie Gayer |
President, Chief Executive Officer and Director |
31/07/2025 |
| Dr. Amy E. McKee, M.D. |
Independent Director |
26/02/2026 |
|
|
|
|
